Jeetvan Patel, PhD

Jeetvan Patel, PhD, is a Health Economist and an expert in real world evidence generation. At Novartis, he leads the HEOR and RWE generation for Radioligand therapies. In this capacity, he leads strategic evidence-generation initiatives to demonstrate value and optimize access across the radioligand pipeline.

Jeetvan applies a multidisciplinary approach—combining epidemiology, modeling, and observational data—to inform strategy and engage payers. His leadership extends to mentoring junior scientists and fostering cross-functional collaborations in outcomes research. Over nearly two decades in pharmaceutical HEOR, he has emerged as a recognized leader in evidence generation, shaping evidence frameworks that support patient access to novel radioligand therapies.

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none